AFP and hepatocellular carcinoma: Measurement of AFP–L3%—the proportion of AFP–L3 to total AFP—improves the specificity of HCC diagnosis, but demonstrates moderate to low sensitivity for early HCC detection, making it most useful for confirming HCC in patients with elevated AFP, rather than as a standalone screening tool [52].